BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21672190)

  • 21. Analysis of soluble angiogenic factors in Crohn's disease: a preliminary study.
    Dueñas Pousa I; Maté Jiménez J; Salcedo Mora X; Abreu MT; Moreno Otero R; Gisbert JP
    Gastroenterol Hepatol; 2007 Nov; 30(9):518-24. PubMed ID: 17980128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant decrease in maternal serum concentrations of angiopoietin-1 and -2 after delivery.
    Keikkala E; Hytinantti T; Wathén KA; Andersson S; Vuorela P
    Acta Obstet Gynecol Scand; 2012 Aug; 91(8):917-22. PubMed ID: 22583143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiopoietin-2 and Survival in Peripheral Artery Disease Patients.
    Höbaus C; Pesau G; Herz CT; Wrba T; Koppensteiner R; Schernthaner GH
    Thromb Haemost; 2018 Apr; 118(4):791-797. PubMed ID: 29618157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depressed expression of angiogenic growth factors in the subacute phase of myocardial ischemia: a mechanism behind the remodeling plateau?
    Siddiqui AJ; Fischer H; Widegren U; Grinnemo KH; Hao X; Månsson-Broberg A; Sylvén C; Gustafsson T
    Coron Artery Dis; 2010 Mar; 21(2):65-71. PubMed ID: 20016374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of the angiopoietin-2/angiopoietin-1 and angiopoietin-1/Tie-2 ratios for early sepsis in an emergency department.
    Fang Y; Li C; Shao R; Yu H; Zhang Q; Zhao L
    Crit Care; 2015 Oct; 19():367. PubMed ID: 26463042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiopoietin-2 as a Prognostic Factor in Patients with Incurable Stage IV Colorectal Cancer.
    Munakata S; Ueyama T; Ishihara H; Komiyama H; Tsukamoto R; Kawai M; Takahashi M; Kojima Y; Tomiki Y; Sakamoto K
    J Gastrointest Cancer; 2021 Mar; 52(1):237-242. PubMed ID: 32166589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
    Lim HS; Blann AD; Chong AY; Freestone B; Lip GY
    Diabetes Care; 2004 Dec; 27(12):2918-24. PubMed ID: 15562207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors.
    Serefhanoglu S; Goker H; Buyukasik Y; Turgut M; Sayinalp N; Haznedaroglu IC; Aksu S; Akman U; Ozcebe OI
    Ann Hematol; 2009 Jul; 88(7):667-71. PubMed ID: 19082594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features.
    Figueroa-Vega N; Sanz-Cameno P; Moreno-Otero R; Sánchez-Madrid F; González-Amaro R; Marazuela M
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1145-53. PubMed ID: 19141578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community.
    Lieb W; Zachariah JP; Xanthakis V; Safa R; Chen MH; Sullivan LM; Larson MG; Smith HM; Yang Q; Mitchell GF; Vita JA; Sawyer DB; Vasan RS
    Circ Cardiovasc Genet; 2010 Jun; 3(3):300-6. PubMed ID: 20348331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating angiopoietins in idiopathic pulmonary arterial hypertension.
    Kümpers P; Nickel N; Lukasz A; Golpon H; Westerkamp V; Olsson KM; Jonigk D; Maegel L; Bockmeyer CL; David S; Hoeper MM
    Eur Heart J; 2010 Sep; 31(18):2291-300. PubMed ID: 20601390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma concentrations of angiopoietin-1, angiopoietin-2 and Tie-2 in colon cancer.
    Engin H; Üstündağ Y; Tekin İÖ; Gökmen A; Ertop Ş; İlikhan SU
    Eur Cytokine Netw; 2012 Jun; 23(2):68-71. PubMed ID: 22728324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiopoietin-1, angiopoietin-2 and tie-2 in the coronary circulation of patients with and without coronary collateral vessels.
    Mitsuma W; Kodama M; Hirono S; Ito M; Ramadan MM; Tanaka K; Hoyano M; Saigawa T; Kashimura T; Fuse K; Okura Y; Aizawa Y
    Circ J; 2007 Mar; 71(3):343-7. PubMed ID: 17322632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma markers of angiogenesis in pregnancy induced hypertension.
    Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
    Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
    Lim HS; Lip GY; Blann AD
    Atherosclerosis; 2005 May; 180(1):113-8. PubMed ID: 15823283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiopoietin-2 levels predict mortality in CKD patients.
    David S; John SG; Jefferies HJ; Sigrist MK; Kümpers P; Kielstein JT; Haller H; McIntyre CW
    Nephrol Dial Transplant; 2012 May; 27(5):1867-72. PubMed ID: 21976741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure.
    Eleuteri E; Di Stefano A; Tarro Genta F; Vicari C; Gnemmi I; Colombo M; Mezzani A; Giannuzzi P
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):607-14. PubMed ID: 21450636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia?
    Kamal M; El-Khayat W
    J Investig Med; 2011 Oct; 59(7):1147-50. PubMed ID: 21849906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.
    Kumar NP; Velayutham B; Nair D; Babu S
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):93-99. PubMed ID: 28157471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.